Type-I interferon receptor expression: Its circadian rhythm and downregulation after interferon-α administration in peripheral blood cells from renal cancer patients-Reference-Cited by-同舟云学术

Type-I interferon receptor expression: Its circadian rhythm and downregulation after interferon-α administration in peripheral blood cells from renal cancer patients

Published:2009-03-18 Issue:4 Volume:16 Page:356-359
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:

Author:

Shiba Masahiro,Nonomura Norio,Nakai Yasutomo,Nakayama Masashi,Takayama Hitoshi,Inoue Hitoshi,Tsujimura Akira,Nishimura Kazuo,Okuyama Akihiko

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2009.02265.x/fullpdf

Reference23 articles.

1. Interferon-alpha and survival in metastatic renal carcinoma: Early results of a randomised controlled trial;Medical Research Council Renal Cancer Collaborators;Lancet,1999

2. Prospective randomized trial of interferon alfa-2a plus vinblastine vs vinblastine alone in patients with advanced renal cell cancer;Pyrhonen;J. Clin. Oncol.,1999

3. Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling;Domanski;J. Biol. Chem.,1995

4. Genetic transfer of a functional human interferon alpha receptor into mouse cells: Cloning and expression of its cDNA;Uze;Cell,1990

5. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration;Poynard;Hepatology,1996

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal cancer: signaling pathways and advances in targeted therapies;MedComm;2024-08

2. Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants;Antiviral Therapy;2023-01-24

3. Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences;Cancers;2023-01-07

4. Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal Study;European Urology;2022-06

5. Type I interferons are important co‐stimulatory signals during T cell receptor mediated human MAIT cell activation;European Journal of Immunology;2019-11-14